🗓️Klíčové events of the week! 🌟

This week will be the most important week of the whole results season for me, since there are so many results and events, I'm just attaching my list of the most important news:

❌Monday
Prague Stock Exchange closed due to a public holiday

Results:
Before the markets open: ON Semi $ON

After markets close: Ford $F

📊Tuesday

US Consumer Confidence

JOLTS - Job...
Read more

The anti-obesity drug industry was in 2023 valued at $5.6 billion and will exhibit a CAGR of 27% between 2024 and 2032 (expert opinion).

$LLY, $NVO and others are creating drugs like - Ozempic, Wegovy, Mounjaro and Zepbound - These are blockbusters in terms of weight loss market in my opinion. But which companies may have the best chance to take the biggest bite of that...
Read more

📆 Overview of interesting things for the upcoming week! 🚀

This week I will be watching mostly company results. With the investor sentiment from last week, I think wonders will happen when the markets announce earnings.

🔍 Monday:
ISM Services PMI - This index measures economic activity in the service sector and often serves as an indicator of overall economic health.

Earnings: Befor...
Read more

Analysts at Berenberg have raised their estimates for the global obesity market to $150 billion by 2035, up from $125 billion previously. This revision is the result of positive data on co-morbidities and advances in competing studies. Berenberg recommends buying shares of $LLY and Zealand Pharma, while he recommends holding on to shares of $NVO.

What are your thoughts on...
Read more

📊 Investment Calendar 📆

Earnings season is in full swing, and with it comes more exciting news. Here is a summary of the news I will be following.

Monday: I'll only be watching company results.

📈 Earnings: Before the markets open, I'll be watching Domino's Pizza $DPZ, SoFi Technologies $SOFI and ON Semiconductor $ON. After the close, just the results of Paramount $PARA and Logit...
Read more

📈💡 New and interesting player on the pharmaceutical market! 💊🔍

One of the most discussed topics in the pharmaceutical market is the treatment of obesity and diabetes. Only two companies are behind many successful drugs such asOzempic, Rybelsus and Saxenda: Novo Nordisk $NVO and Eli Lilly $LLY. These companies have had significant success in the treatment of diabetes and...
Read more

ELI LILLY AS A POSSIBLE GAMECHANGER IN THE HEALTHCARE SECTOR

-Eli Lilly $LLY is currently the most valuable healthcare company in the world, valued at around $550 billion.

- The company's stock has been one of the most sought-after in the healthcare sector.

- Despite the high value, there are many growth opportunities for Eli Lilly in the pharmaceutical industry.

- Donanemab is a...
Read more

Today I took a closer look at $LLY, which I like very much and would like to include shares of this company in my portfolio, however the stock is very expensive at the moment and I would personally buy up to under $450.

How do you view this company and do you have shares of this company in your portfolio?

Hey investors, whose results are you waiting for this week? I only have $PFE and $LLY, but I'll definitely check out Palantir, SoFi, chipmakers (AMD, Qualcomm) and PayPal.

Healthcare sector, one of the most popular sectors for investors, especially value investors. What are we going to think, health is the one thing we should protect most in our lives, and companies that are involved in this will profit from it perhaps indefinitely. Thanks to them, our society is able to live to a ripe old age. who are your favourites in this sector? For me, I...
Read more

US pharmaceutical company Eli Lilly and Company reported its results today, which beat expectations and $LLY shares are up more than 15% in response. Fundamentals are quite solid and the stock is up over 40% for the year, which I like and since I see potential in healthcare and I like pharmaceutical and medical companies, I like this company even more :D. The stock may be up,...
Read more